January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
According to market projections, the global bone marrow transplant market, valued at USD 10.75 billion in 2024, is anticipated to reach USD 16.76 billion by 2034, growing at a CAGR of 4.54% over the next decade. In 2024, North America led the bone marrow transplant market, with autologous transplants and leukemia treatments dominating. Hospitals we...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the fastest growth. Immunosuppressants dominated treatment, while monoclonal antibodies are poised to ris...
April 21, 2026
According to forecasts, the global peptide receptor radionuclide therapy market will grow from USD 2.34 billion in 2024 to USD 6.1 billion by 2034, with an expected CAGR of 10.06%. In 2024, North America led the global peptide receptor radionuclide therapy market, with neuroendocrine tumors and therapeutic radiopharmaceuticals dominating. Hospitals...
April 21, 2026
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs market, with Asia Pacific set for the fastest growth. Biologics and arthritis treatments dominated, wh...
April 21, 2026
The exosome cell and gene therapy market is booming, driven by its use in treating cancer, rare, and genetic diseases. With tech like AI and automation, personalized therapies are improving care. North America leads, while Asia Pacific sees rapid growth and Europe grows steadily....
April 21, 2026
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed drugs market, with neurology and zip dose tech dominating. Asia Pacific is set to grow fastest, dri...
April 21, 2026
According to market projections, the hemophilia sector is expected to grow from USD 14.34 billion in 2024 to USD 27.27 billion by 2034, reflecting a CAGR of 6.64%. Hemophilia affects over 1.1M globally, often undiagnosed. Advances like gene therapy and long-acting treatments are reshaping care. In 2024, North America led the market share by 50%, wh...
April 21, 2026
Drug products with high concentrations of monoclonal antibodies are a unique class of biopharmaceuticals. High-concentration monoclonal antibodies are administered subcutaneously, which helps improve patient compliance and lower the frequency of hospital patient visits compared to other monoclonal antibody products. Given their potential to save an...
April 21, 2026
Market insights predict, the breast implants industry is expected to grow from USD 2.72 billion in 2024 to USD 5.62 billion by 2034, driven by a CAGR of 7.54%. Breast reconstruction is gaining traction for its psychosexual benefits post-cancer surgery. Implants, expanders, flaps, and fat grafting offer effective options. In 2024, North America led ...
April 21, 2026
Market insights predict, the radiopharmaceutical industry is expected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034, driven by a CAGR of 7.57%. The research in radiopharmaceuticals is introducing new approaches that enhance the specificity and diagnostic as well as therapeutic effectiveness. Thus, the new targeting agents, innov...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
